Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. G.J. (Gertrude) Nieuwenhuijs-Moeke

Research interests

As a physician-scientist my long-term research interests are perioperative injury and pharmacological organ protection with a particular interest in organ transplantation, the role of the immune system during the perioperative period and pleiotropic effects of anaesthetic agents. It is key for the future benefit of our patients to search for patient- and organ-protective strategies that reduce complications and improve outcomes. This is an important paradigm shift in the way we look at anaesthesiology, from a facilitating role in surgical care to a central role in perioperative medicine and it extends the role of the anaesthesiologist beyond the operating theatre to the wider community.


Association between anaesthesia-related factors and postoperative neurocognitive disorder: a post-hoc analysis

Pathophysiological Changes in the Hemostatic System and Antithrombotic Management in Kidney Transplant Recipients

Peri-Operative Kinetics of Plasma Mitochondrial DNA Levels during Living Donor Kidney Transplantation

Prehabilitation in Adult Solid Organ Transplant Candidates

Pro-Con Debate: Should All General Anesthesia Be Done Using Target-Controlled Propofol Infusion Guided by Objective Monitoring of Depth of Anesthesia?

Urinary Biomarkers in a Living Donor Kidney Transplantation Cohort-Predictive Value on Graft Function

Immune Modulatory Effects of Nonsteroidal Anti-inflammatory Drugs in the Perioperative Period and Their Consequence on Postoperative Outcome

Systemic and Renal Dynamics of Free Sulfhydryl Groups during Living Donor Kidney Transplantation

Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation

Corrigendum to 'Propofol-based anaesthesia versus sevoflurane-based anaesthesia for living donor kidney transplantation: results of the VAPOR-1 randomized controlled trial' (Br J Anaesth 2017; 118: 720-32)

Read more


Delaying renal replacement therapy (RRT)

VAPOR-2 study